Fagron Compounding Services is recalling approximately 109,320 syringes of bevacizumab (Avastin) Injection, 1.25mg/0.05mL (0.12 mL Fill). The recall was initiated because of a lack of assurance of sterility, which means the product may not be completely free of microorganisms. These sterile single-dose syringes are used as injections, often for ophthalmic or oncological conditions, and were distributed nationwide in the United States.
A lack of sterility in an injectable medication poses a significant risk of infection to the patient. If a contaminated product is injected, it can cause serious illness or permanent injury, particularly if injected into sensitive areas like the eye.
Manufactured by Fagron Sterile Services, 8710 E 34th St N. Wichita, KS 67226.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.